Origin Therapeutics to Begin Trading on the CSE Under the Symbol 'ORIG'
globenewswire.com
news
2022-06-02 00:00:00

Vancouver, B.C., June 02, 2022 (GLOBE NEWSWIRE) -- Â Origin Therapeutics Holdings Inc. (the 'Company' or 'Origin Therapeutics'), an actively managed, psychedelics industry-focused investment issuer, is pleased to announce that it has received approval to list its common shares on the Canadian Securities Exchange (the "CSE"). The common shares will commence trading under the trading symbol "ORIG" on June 6, 2022. 'The psychedelics sector has the potential to be very disruptive,' said Alexander Somjen, CEO of Origin Therapeutics.
